Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01643525 · ClinicalTrials.gov registry record
Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke
A clinical trial, sponsored by Jan Medical.
- Terminated
- Registry status
- 29
- Enrollment target
NCT01643525: Clinical Trial study, sponsored by Jan Medical.
NCT01643525 is a clinical trial that was terminated before completion, run by Jan Medical. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01643525 was terminated before completion, sponsored by Jan Medical.
- TERMINATED
- Registry status
- 29 participants
- Enrollment target
Study Summary
That the Jan Medical Nautilus NeuroWaveTM system provides significantly higher sensitivity to hyper acute ischemic stroke than does CT.
Primary Outcome
Count the number of participants with device related adverse events
Interventions
- DEVICE Nautilus NeuroWaveTM System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-12 |
Why NCT01643525 stopped before completion
NCT01643525 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Nautilus NeuroWaveTM System is the first listed.
NCT01643525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01643525 about?
NCT01643525 is a clinical study titled "Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke". That the Jan Medical Nautilus NeuroWaveTM system provides significantly higher sensitivity to hyper acute ischemic stroke than does CT.
What is the current status of trial NCT01643525?
This trial is currently terminated. The enrollment target is 29 participants. The study started on 2012-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01643525?
The interventions under investigation include: Nautilus NeuroWaveTM System (DEVICE).
Who is sponsoring clinical trial NCT01643525?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia